- Report
- February 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- December 2023
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- November 2023
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- November 2023
- 250 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- November 2023
- 250 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- March 2024
- 141 Pages
Global
From €3746EUR$3,899USD£3,221GBP
- Report
- January 2024
- 230 Pages
Global
From €2393EUR$2,490USD£2,057GBP
- Report
- January 2024
- 150 Pages
Global
From €4660EUR$4,850USD£4,007GBP
- Report
- February 2024
- 177 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- February 2024
- 190 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- November 2023
- 170 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- October 2023
- 177 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- July 2023
- 111 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- July 2023
- 145 Pages
Global
From €4756EUR$4,950USD£4,090GBP
- Report
- February 2024
- 204 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- November 2023
- 162 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Report
- October 2023
- 164 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Report
- February 2024
Global
From €4756EUR$4,950USD£4,090GBP
- Report
- October 2023
- 145 Pages
Global
From €3027EUR$3,150USD£2,603GBP
- Report
- February 2024
- 120 Pages
Global
From €4564EUR$4,750USD£3,924GBP
The Companion Diagnostics market is a subset of the biotechnology industry that focuses on the development and commercialization of diagnostic tests that are used to identify patients who are likely to benefit from a particular therapeutic. These tests are used to identify the presence of a specific biomarker or genetic mutation that is associated with a particular therapeutic. The Companion Diagnostics market is driven by the increasing demand for personalized medicine, which is tailored to the individual patient's genetic makeup. This has led to the development of more sophisticated tests that can detect a wider range of biomarkers and mutations.
The Companion Diagnostics market is highly competitive, with a number of companies offering a range of tests. Examples of companies in the market include Roche Diagnostics, Abbott Laboratories, Qiagen, Illumina, and Thermo Fisher Scientific. Show Less Read more